Prelude Therapeutics (PRLD) Total Non-Current Liabilities (2019 - 2026)
Prelude Therapeutics' Total Non-Current Liabilities was $52.91 million in Q2 2026, up 46.5% from $36.11 million a year earlier but down 6.6% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Prelude Therapeutics came in at $69.84 million, up 70.5% from FY2024.
- Total Non-Current Liabilities has now increased for five consecutive years, with a five-year compound annual growth rate of 43.8% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $40.97 million in FY2024 (+10.0%), $37.24 million in FY2023 (+71.6%), $21.7 million in FY2022 (+13.0%) and $19.2 million in FY2021 (+68.8%).
- Quarterly Total Non-Current Liabilities has moved between $15.19 million (Q2 2023) and $69.84 million (Q4 2025) over five years.
- Compared with a year earlier, Total Non-Current Liabilities has increased for three straight quarters, with growth averaging 37.4% over the last eight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2024 (growth of 155.4%); the worst was Q3 2023 (a decline of 21.6%).
- Per Business Quant data, PRLD's Total Non-Current Liabilities in the three quarters before Q2 2026 was $56.68 million (Q1 2026), $69.84 million (Q4 2025) and $33.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Prelude Therapeutics | 347.31 Mn | -249.99 Mn | - | 52.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.91 Mn |
| Mar 31, 2026 | 56.68 Mn |
| Dec 31, 2025 | 69.84 Mn |
| Sep 30, 2025 | 33.32 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Mar 31, 2025 | 35.05 Mn |
| Dec 31, 2024 | 40.97 Mn |
| Sep 30, 2024 | 37.64 Mn |
| Jun 30, 2024 | 38.80 Mn |
| Mar 31, 2024 | 33.10 Mn |
| Dec 31, 2023 | 37.24 Mn |
| Sep 30, 2023 | 16.89 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 19.66 Mn |
| Dec 31, 2022 | 21.70 Mn |
| Sep 30, 2022 | 21.56 Mn |
| Jun 30, 2022 | 15.81 Mn |
| Mar 31, 2022 | 16.46 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Dec 31, 2020 | 11.38 Mn |
API Access
Prelude Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();